Skip to main content

GOLDMAN SACHS GROUP INC

Position in AVTX — Avalo Therapeutics, Inc.

CIK 886982 NEW YORK, NY

Position in AVTX

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$17,487,993
+$16,590,611 QoQ
Shares Held
946,320
+1474.4% QoQ
Ownership
1.76%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#25
of 126 holders
Holding Since
Jun 2020
15 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in AVTX Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

GOLDMAN SACHS GROUP INC holds $13,040,380,016 across 360 Biotechnology names. AVTX ranks #121 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in AVTX

Export CSV
15 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $17,487,993 946,320
2026-03-31 $897,382 60,106
2025-12-31 $1,186,084 65,313
2023-03-31 $56,456 32,261
2022-12-31 $166,864 33,108
2022-09-30 $118,338 35,644
2022-06-30 $324,825 649,653
2022-03-31 $380,540 524,884
2021-12-31 $1,164,948 685,264
2021-09-30 $1,466,406 672,664
2021-06-30 CERC 453,629
2021-03-31 CERC 477,657
2020-12-31 CERC 389,906
2020-09-30 CERC 162,337
2020-06-30 CERC 145,500